Hair Loss News

Neosh101 Announces Positive Phase 2 Trial Results

Date Added: January 4, 2007
Summary:
January 04, 2007 -- Neosil, Inc., a privately held dermatology-focused pharmaceutical company, today announced positive Phase 2a clinical data demonstrating that its lead product, NEOSH101, increased hair growth significantly in men.

Hair Regeneration Research Grant Awarded to Intercytex

Date Added: December 7, 2006
Summary:
U.K. Department of Trade has awarded Intercytex, a cell regeneration research company, a £1.85 million, grant to develop an automated manufacturing process for hair regeneration therapy for the treatment of male pattern baldness.

Trial Drug Promises Improved Post-Surgical Scar Appearance

Date Added: December 6, 2006
Summary:
Renovo Group, leading scar prevention researcher and biopharmaceutical company, completed Phase 2 of Juvista trials reported in October of 2006. Injected at the time of surgery, Juvista is demonstrating marked improvement in the appearance of post-surgical scarring. The phase 2 results were confirmatory results supporting positive phase 1 results.

Japanese Study Validates Hasson & Wong Lateral Slit Technique

Date Added: December 5, 2006
Summary:
Japanese Study supports Hasson & Wong Lateral Slit Technique for natural alignment of hair.